Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients

NCT ID: NCT07268781

Last Updated: 2025-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

102 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-20

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

People with diabetes often experience abnormal blood fat levels, known as dyslipidemia, which increase the risk of heart disease and stroke. The aim of the study, researchers are exploring a natural and practical solution through a healthy snack in the form of cookies. These cookies are made from Golden Rice, which is rich in beta-carotene as a natural antioxidant, and Piper crocatum (red betel leaf) extract, which contains polyphenols and flavonoids that may help lower cholesterol, reduce inflammation, and protect blood vessels. In this study, patients with diabetes will consume the cookies for 28 days, and their blood fat levels will be measured before and after the intervention. The results will then be compared with those of a control group who receive the Golden rice cookies without piper crocatum extract. This research aims to show that Golden Rice with Piper crocatum extract cookies can reduce bad cholesterol and triglycerides, increase good cholesterol, and serve as a safe, affordable, and acceptable food option to support daily diabetes care. If successful, this approach may offer patients and families a simple way to help prevent complications and improve quality of life, alongside regular treatment and lifestyle changes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This clinical trial evaluates the effect of Golden Rice cookies enriched with Piper crocatum (red betel leaf) extract on lipid profile control in patients with type 2 diabetes mellitus. The intervention is designed as a short-term, food-based strategy to complement existing diabetes management by integrating functional food into daily dietary practice.

The rationale for this approach is based on evidence that beta-carotene from Golden Rice and polyphenols from Piper crocatum exert antioxidant, anti-inflammatory, and lipid-lowering activities. Combining these bioactive compounds in the form of cookies provides a culturally acceptable, affordable, and practical dietary intervention. The cookie format was selected due to its high acceptance, ease of distribution, and potential to improve adherence compared with capsule or extract preparations.

This trial uses a controlled pre-post design to compare changes in lipid biomarkers between the intervention and control groups over 28 days. Key outcomes include serum levels of LDL cholesterol, HDL cholesterol, triglycerides, and total cholesterol. The study also explores potential synergistic effects on oxidative stress and inflammatory processes associated with dyslipidemia in diabetes.

By translating the concept of functional food into a practical dietary item, this study aims to generate evidence for its role as an adjunctive therapy in diabetes care. Findings are expected to inform future dietary guidelines and nursing interventions, particularly in community-based settings where accessibility, patient adherence, and cost-effectiveness are critical considerations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus (DM) Dyslipidemia Lipid Profile Functional Food Nutritional Intervention Cardiovascular Risk Factor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

This study is an interventional clinical trial with a parallel-group design to evaluate the effect of Golden Rice cookies enriched with Piper crocatum extract on lipid profile control in patients with Type 2 Diabetes Mellitus. Participants will be divided into two groups: the intervention group, which will receive Golden Rice cookies containing Piper crocatum extract for 28 consecutive days, and the control group, which will receive standard care (placebo) without the functional food intervention. The study follows a pre-test and post-test control group design, where lipid profile parameters including total cholesterol, LDL, HDL, and triglycerides will be assessed at baseline and after the 28-day intervention period. The allocation is randomized, while masking is not applied due to the nature of the dietary intervention. The primary purpose of this study is treatment, aiming to improve lipid metabolism, reduce dyslipidemia, and prevent cardiovascular complications in patients with
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
Participants will not be informed about whether they are in the intervention or control group, since both groups will receive packaged cookies that appear identical. Investigators and care providers will know the allocation in order to ensure proper delivery of the intervention, but outcome assessors and laboratory personnel measuring lipid profiles will remain blinded to minimize bias.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Golden Rice cookies With Piper Crocatum extract

Participants will receive Golden Rice cookies enriched with Piper crocatum extract as a daily dietary supplement for 28 consecutive days. The cookies are formulated as a functional food, providing β-carotene from Golden Rice and polyphenols from Piper crocatum, which have antioxidant, anti-inflammatory, and lipid-modulating properties. The intervention aims to improve lipid metabolism by reducing total cholesterol, LDL, and triglycerides while increasing HDL levels in patients with Diabetes Mellitus.

Group Type EXPERIMENTAL

Golden Rice cookies with Piper crocatum Extract

Intervention Type DIETARY_SUPPLEMENT

Golden Rice cookies enriched with Piper crocatum extract, formulated as a functional food containing β-carotene and polyphenols with antioxidant, anti-inflammatory, and lipid-modulating properties. Participants will consume the cookies daily for 28 consecutive days in addition to their standard diabetes management. This intervention is designed to improve lipid metabolism and reduce dyslipidemia in patients with Diabetes Mellitus.

Active Comparator (Control)

Participants will receive Golden Rice cookies without Piper crocatum extract, identical in appearance and packaging to the intervention cookies, for 28 consecutive days. This control is designed to maintain participant blinding and to serve as a comparison for evaluating the specific effects of Piper crocatum extract on lipid profile outcomes.

Group Type ACTIVE_COMPARATOR

Placebo Cookies (Control)

Intervention Type DIETARY_SUPPLEMENT

Placebo cookies without Golden Rice or Piper crocatum extract, identical in appearance, taste, and packaging to the intervention cookies. Participants will consume placebo cookies daily for 28 consecutive days along with their standard diabetes management. This placebo is used to maintain participant blinding and provide a valid comparison.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Golden Rice cookies with Piper crocatum Extract

Golden Rice cookies enriched with Piper crocatum extract, formulated as a functional food containing β-carotene and polyphenols with antioxidant, anti-inflammatory, and lipid-modulating properties. Participants will consume the cookies daily for 28 consecutive days in addition to their standard diabetes management. This intervention is designed to improve lipid metabolism and reduce dyslipidemia in patients with Diabetes Mellitus.

Intervention Type DIETARY_SUPPLEMENT

Placebo Cookies (Control)

Placebo cookies without Golden Rice or Piper crocatum extract, identical in appearance, taste, and packaging to the intervention cookies. Participants will consume placebo cookies daily for 28 consecutive days along with their standard diabetes management. This placebo is used to maintain participant blinding and provide a valid comparison.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 18-59 years.
* Patients diagnosed with Type 2 Diabetes Mellitus based on medical records at Tambu Primary Health Center.
* Able to read and communicate effectively with healthcare staff.
* Permanent resident in the Tambu area.
* Willing to participate in the intervention and follow-up evaluations for the duration of the study.

Exclusion Criteria

* Pregnant or breastfeeding women, or those currently undergoing a pregnancy program.
* Patients with mental health disorders.
* Patients with severe comorbidities affecting lipid metabolism, such as chronic kidney disease (CKD), hepatitis, congestive heart failure, stroke, or acute coronary syndrome within the past 3 months.
* Patients who have consumed herbal supplements or high-dose antioxidants within the last month.
* Patients with severe gastrointestinal disorders, such as chronic diarrhea.
* Patients with a history of allergy to any ingredients used in the study intervention.
Minimum Eligible Age

18 Years

Maximum Eligible Age

59 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hasanuddin University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Altje Suwardi Abram

S.Kep.,Ns

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ANDINA SETYAWATI, PhD, S.Kep., Ns., M.Kep.

Role: STUDY_DIRECTOR

Hasanuddin University, Faculty of Nursing

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tambu Primary Health Center (Puskesmas Tambu)

Donggala, Central Sulawesi, Indonesia

Site Status

RSUD Anutapura Palu

Palu, Central Sulawesi, Indonesia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Indonesia

References

Explore related publications, articles, or registry entries linked to this study.

Setyawati A, Saleh A, Tahir T, Yusuf S, Syahrul S, Aminuddin A, Raihan M, Jafar N, Hamzah H, Arfian N. Matrix Metalloproteinase-9 Testing of Golden Rice Cookies With Piper Crocatum Active Extract for Preventing Foot Ulcers in Patients With Diabetes: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2024 Feb 29;13:e49940. doi: 10.2196/49940.

Reference Type BACKGROUND
PMID: 38422498 (View on PubMed)

https://jppres.com/jppres/pdf/vol13/jppres25.2499_13.6.1847.pdf

Reference Type RESULT

Setyawati A, Wahyuningsih MSH, Nugrahaningsih DAA, Effendy C, Fneish F, Fortwengel G. Piper crocatum Ruiz & Pav. ameliorates wound healing through p53, E-cadherin and SOD1 pathways on wounded hyperglycemia fibroblasts. Saudi J Biol Sci. 2021 Dec;28(12):7257-7268. doi: 10.1016/j.sjbs.2021.08.039. Epub 2021 Aug 19.

Reference Type RESULT
PMID: 34867030 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://nursing.unhas.ac.id/

Official website of the Faculty of Nursing, Universitas Hasanuddin.

https://unhas.ac.id/

Universitas Hasanuddin official website.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UH2507094

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Curcumin for Type 2 Diabetic Patients
NCT01052597 UNKNOWN PHASE4
Multiple Grain in Type 2 Diabetes
NCT00337337 UNKNOWN PHASE4